Public preview. Funding rounds, founders, and growth signals require a free account.

Apic Bio, Inc.

Develops gene therapies for rare genetic diseases like ALS, Alpha-1 Antitrypsin Deficiency, and neurological disorders.[1][2]

GrowthBiotechCambridge, MA11-50 employees

Total raised

$104.1M

Last round

Convertible Note

$8.3M · Dec 2021

Stage

Growth

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment Apic Bio, Inc. files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.